D3 Lymph Node Dissection Improves Survival Outcomes in Patients With cT2 Colorectal Non-well-differentiated Adenocarcinoma
In Vivo · 2024
DOI: 10.21873/invivo.13505 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, 2024. Verfasst von Liming Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chin…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shen…
- Division of Gastroenterological Surgery, Saitama Medical University International Medical Center, Saitama, Japan.
Zitieren
APA
Wang, L., Song, B., Chen, Y., & Hirano, Y. (2024). D3 Lymph Node Dissection Improves Survival Outcomes in Patients With cT2 Colorectal Non-well-differentiated Adenocarcinoma. In Vivo. https://doi.org/10.21873/invivo.13505
Vancouver
Wang L, Song B, Chen Y, Hirano Y. D3 Lymph Node Dissection Improves Survival Outcomes in Patients With cT2 Colorectal Non-well-differentiated Adenocarcinoma. In Vivo. 2024. doi:10.21873/invivo.13505
BibTeX
@article{Wang2024,
author = {Wang, Liming and Song, Bolun and Chen, Yinggang and Hirano, Yasumitsu},
title = {D3 Lymph Node Dissection Improves Survival Outcomes in Patients With cT2 Colorectal Non-well-differentiated Adenocarcinoma},
journal = {In Vivo},
year = {2024},
doi = {10.21873/invivo.13505}
}
EUVIMED